Acciones Peloton Therapeutics, Inc.
Acciones
PLTX
US70614L1044
Biotecnología e investigación médica
Directores | Puesto | Edad | Desde |
---|---|---|---|
Naseem Zojwalla
CTO | Chief Tech/Sci/R&D Officer | 51 | - |
Corporate Officer/Principal | - | - | |
Peter Stenge
PRN | Corporate Officer/Principal | - | - |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Helen Kim
BRD | Director/Board Member | 61 | 01/11/17 |
Brett A. Ringle
BRD | Director/Board Member | 73 | 01/01/11 |
David Chang
BRD | Director/Board Member | 64 | 01/02/18 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+9,58 % | 115 mil M | |
+12,41 % | 106 mil M | |
-2,59 % | 21,96 mil M | |
-12,38 % | 21,87 mil M | |
-5,29 % | 19,21 mil M | |
-3,35 % | 18,08 mil M | |
-38,57 % | 17,71 mil M | |
+7,51 % | 14,32 mil M | |
+35,67 % | 12,42 mil M |